AI-Discovered Drug Shows Promise in Reversing Aging Markers
The experimental drug rentosertib, developed with artificial intelligence to treat a rare lung condition, appears to reduce biological hallmarks of age.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The story so far
2 publishers have covered this in 2 articles since 7 Sept 2026. The New York Times published first, on 7 September at 15:12 UTC; Latest articles followed 18h 31m later. The most recent article, from Latest articles, appeared on 8 September at 09:43 UTC.
Outlets reporting it: The New York Times (major outlet), Latest articles.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- rentosertib